Document Classification

Section Type: RESULTS

Text: Balsalazide/VSL # 3 was significantly superior to balsalazide alone and to mesalazine in obtaining remission : 24 patients of group A were in remission [per-protocol : 85. 71 % (C. I. 95 % : 62-96), on intention-to-treat : 80 % (C. I. 95 % : 59-91)], while 21 group B [per-protocol : 80. 77 % (C. I. 95 % : 51-82), on intention-to-treat : 77 % (C. I. 95 % : 43-81)] and 16 group C patients [per-protocol : 72. 73 % (C. I. 95 % : 30-75), on intention-to-treat : 53. 33 % (C. I. 95 % : 42-62)] were in remission (p < 0. 02).